retatrutide approval is one of the most exciting medications currently being studied for obesity and metabolic disease-but there's one important thing to understand: It is NOT approved yet. I get asked almost daily, “ RETATRUTIDE (RETA)

Retatrutide is not yet approved by Health Canada or the FDA

Systematic rotation of injection sites is a fundamental practice for patients using injectable medications, essential for preventing complications and maintaining optimal therapeutic outcomes

Medicare GLP-1 Bridge Program, Insurance, and How Omzo Fits In Starting July 1, 2026, eligible Medicare beneficiaries can get select FDA-approved GLP-1 medications - Wegovy, Foundayo, and Zepbound KwikPen - for $50 per month through the CMS Medicare GLP-1 Bridge Program

Carbonated beverages add gas to a GI system that is already moving slowly

Why Menopausal Women Might Consider GLP-1s for Weight Loss Among the unwelcome symptoms of perimenopause (the hormonally turbulent years before periods stop) and menopause, one rises to the top for many women: weight gain

You will need to show up for clinic visits regularly, sometimes for over a year